Abstract. The urokinase cellular receptor (uPAR) recognizes the N-terminal growth factor domain of urokinase-type plasminogen activator (uPA) and is expressed by several cell types.
wild-type animals after UUO (62 Ϯ 20 versus 135 Ϯ 13 units at day 3 UUO; 74 Ϯ 17 versus 141 Ϯ 16 at day 7 UUO; 98 Ϯ 20 versus 165 Ϯ 10 at day 14 UUO; Ϫ/Ϫ versus ϩ/ϩ). In contrast, renal expression of several genes that regulate plasmin activity were similar in both genotypes, including uPA, tPA, PAI-1, protease nexin-1, and ␣2-antiplasmin. Worse renal fibrosis in the uPARϪ/Ϫ mice appears to be TGF-␤-independent, as TGF-␤ activity was actually reduced by 65% in the Ϫ/Ϫ mice despite similar renal TGF-␤1 mRNA levels. Significantly lower levels of the major 2.3-kb transcript and the 69-kd active protein of hepatocyte growth factor (HGF), a known anti-fibrotic growth factor, in the uPARϪ/Ϫ mice suggests a potential link between HGF and the renoprotective effects of uPAR. These data suggest that renal uPAR attenuates the fibrogenic response to renal injury, an outcome that is mediated in part by urokinase-dependent but plasminogenindependent functions.
Progressive renal disease, characterized histologically by tubular atrophy and the accumulation of extracellular matrix proteins in the renal interstitium, is associated with declining renal function (1, 2) . In addition to increased matrix protein synthesis, impaired degradation of interstitial matrix proteins also appears to play an important role in renal fibrogenesis (3) . Although the mechanisms regulating matrix turnover within the renal interstitium are poorly understood, recent studies suggest that the plasmin cascade plays a significant role (4) . In addition to their well-known fibrinolytic activity, the plasminogen activator/plasmin enzymes also have direct and indirect extracellular matrix-degrading actions (5, 6) . Somewhat paradoxically, plasmin also activates the latent fibrogenic cytokine TGF-␤ in vitro, but whether this is a significant in vivo action of plasmin is unclear (7) . The rate-limiting step for plasmin generation is the activity of tissue-type (tPA) and/or urokinasetype (uPA) plasminogen activators. PA activity is tightly regulated at several levels, including pro-enzyme synthesis, extracellular activation of the latent enzymes, and their inhibition by specific inhibitors such as plasminogen activator inhibitor-1 (PAI-1), PAI-2, and possibly protease nexin-1. Within normal kidneys, high levels of uPA are synthesized by renal tubules. Generally undetected in normal kidneys, PAI-1 is expressed de novo during the active phase of renal fibrosis (reviewed in reference 8). Although mice with the PAI-1 null mutation develop less severe renal (9) and pulmonary fibrosis (10) than do wild-type mice, it remains unclear whether the blunted fibrogenic response is entirely due to inhibition of plasminogen activator/plasmin proteolytic activity or also related to the pro-inflammatory and pro-angiogenic effects of PAI-1.
A cellular receptor has been identified for the N-terminal growth factor domain of uPA (uPAR), also known as CD87 (11, 12) . It is expressed by cells of several lineages, including lymphohematopoietic cells (monocytes, neutrophils, and activated T cells), resident kidney cells (glomerular and tubular epithelial cells and mesangial cells), endothelial cells, fibroblasts, and myofibroblasts (5, (13) (14) (15) (16) (17) (18) . This highly glycosylated 50-kD to 65-kD protein is linked to the plasma membrane by glycosylphosphatidylinositol (GPI). The uPAR binds to both the latent and active form of uPA. Once receptor-bound, the latent enzyme can be activated while the active enzyme retains its enzymatic activity. The inhibitor PAI-1 may also bind to the receptor-bound enzyme, an interaction that promotes internalization and degradation of uPA and PAI-1 (5, 19) . Soluble forms of uPAR also exist, generated by proteolytic cleavage of the transmembrane domain (20) .
It is now evident that uPAR is a multifunctional receptor that is involved not only in cell-surface uPA activity and plasmin generation, but also in mediating protease-independent effects, including cell adhesion and migration and outside-in signaling (12, 21) . Less clear is the role of receptor-bound uPA and subsequent plasmin generation in the context of tissue remodeling. In particular, little is known about the expression and function of uPAR during renal fibrosis. Immunohistochemical studies have reported uPAR expression on normal human tubules in one study (18) but not in another (16) . Increased kidney uPAR expression has been described in several renal disease states such as endotoxemia (15, 22) , acute tubular necrosis (16), thrombotic microangiopathy (16), nephrotoxic serum nephritis (23), pyelonephritis (22) , and chronic allograft rejection (24) . The present study was designed to investigate the functional role of uPAR in the renal fibrogenic response to sustained injury by investigating the response to ureteral obstruction in uPAR-deficient mice compared with wild-type mice of the same genetic background.
Materials and Methods

Animals and Experimental Design
UPARϪ/Ϫ and ϩ/ϩ mice on a C57Bl6 background were bred in our animal facility and allowed to grow to a minimum weight of 20 g before the initiation of the study (25) . The genotypes of the mice were confirmed by Southern blot analysis of DNA extracted from tails. Groups of weight-matched and gender-matched uPAR-deficient and wild-type mice were studied 3, 7, and 14 d after unilateral ureteral obstruction (UUO) and 7 d after sham surgery (n ϭ 8 per group). UUO surgery was performed under general anesthesia. The left ureter was ligated with 4.0 silk at two separate points in the UUO groups. All mice were sacrificed by exsanguination under general anesthesia. All procedures were performed in compliance with the guidelines established by National Research Council Guide for the Care and Use of Laboratory Animals.
Kidney Tissue Preparation
After exsanguination, the left kidney was procured, the capsule removed, and the kidney weighed. The kidney was divided longitudinally and subdivided. One half was prepared for histologic studies: one piece (approximately one third) was fixed in 10% buffered formalin and paraffin-embedded; the remaining piece (approximately two thirds) was imbedded in Tissue-Tek OCT compound (Sakura Finetek, Torrence, CA) and snap-frozen. Sections from the second half kidney were frozen at Ϫ80°C for total collagen measurement (approximately one fourth) and for the total RNA and protein extraction (approximately three fourths).
Analysis of Tubulointerstitial Fibrosis
Total renal collagen was measured biochemically as described previously (26) . In brief, an accurately weighed portion of the kidney was homogenized in distilled water, hydrolyzed in 10N HCl and incubated at 110°C for 18 h. The hydrolysate was dried by speed vacuum centrifugation and redissolved in buffer (25 g of citric acid, 6 ml of glacial acetic acid, 60 g of sodium acetate, and sodium hydroxide [17 g in 500 ml], pH 6.0). Total hydroxyproline in the hydrolysate was determined according to the chemical method of Kivirikko et al. (27) . Total collagen in the tissue was calculated on the assumption that collagen contains 12.7% hydroxyproline by weight. Final results were expressed as g/mg kidney wet weight.
Kidney sections (day 14 UUO and sham) were stained with Masson trichrome (Sigma, St. Louis, MO), and the percent aniline bluestained tubulointerstitial area was measured using a point-counting method (28) .
Immunohistology
Immunohistochemical studies were performed on 4-m paraffinembedded renal sections. Primary antibodies used were rabbit antihuman LDL receptor-related protein (LRP) provided by Dr. D.K. Strickland, American Red Cross, Rockville, MD (29) , rabbit antimouse urokinase (American Diagnostica Inc., Greenwich, CT), rabbit anti-human TGF-␤ (Santa Cruz Biotechnology, Santa Cruz, CA), and mouse anti-human HGF (30) . Immunoperoxidase staining was performed using the ABC ELITE kit (Vector Laboratories Inc., Burlingame, CA). Sections stained with the secondary antibodies alone were negative. For HGF staining, the primary and secondary antibodies were pre-complexed before incubation with the tissue sections to minimize crossreactivity (31) .
To evaluate the extent of tubular injury, sections were stained with biotinylated Phaseolus vulgaris agglutinin-E (PHA-E) (Vector Laboratories Inc.), a lectin that binds to proximal tubular brush border (32) or with a mouse anti-kidney-specific cadherin (Ksp) monoclonal antibody (Zymed Laboratories Inc, San Francisco, CA), which is expressed on the basolateral membrane of collecting ducts (33) . PHA-E staining was used to grade tubular injury on a scale of 1 to 4 as described by Mizuno et al. (34) . Loss of Ksp-cadherin expression was determined as a measure of early tubular injury and expressed as % positive tubules.
In Situ Hybridization
uPAR in situ hybridization was performed as described previously using a 35 S-labeled riboprobe prepared using the Riboprobe Combination System-T3/T7 RNA Polymerase kit (Promega Corp., Madison, WI) (35) . In brief, formalin-fixed, paraffin-embedded 4-m kidney tissue sections were deparaffinized and rehydrated using standard procedures. Sections were washed with 0.5ϫ SCC and digested with 10 g/ml proteinase K (Sigma). Prehybridization was performed for 2 h by adding 50 l of prehybridization buffer (0.3 M NaCl, 20 mM Tris, pH 8.0, 5 mM ethylenediaminetetraacetic acid, 1ϫ Denhardt solution, 10% dextran sulfate, 10 mM dithiothreitol, and 50 g/ml yeast tRNA). Hybridization was initiated by adding 500,000 cpm of the 35 S-labeled uPAR riboprobe (sense or anti-sense) in 50 l of prehybridization buffer and incubated overnight at 50°C. Sections were treated with RNase A (20 g/ml; Sigma) followed by three high-stringency washes in 0.1ϫ SSC/0.5% Tween 20 (Sigma) for 40 min at 50°C and several 2ϫ SSC washes. After the tissue was dehydrated and air-dried, it was dipped in NTB2 emulsion, (Kodak, Rochester, NY) and developed in the dark for 10 wk. After development, the sections were counterstained with hematoxylin and eosin, dehydrated, and cover-slipped.
Northern Blot Analysis
Total kidney RNA was isolated by the phenol/guanidine isothiocyanate extraction method using TRIzol-BRL reagent (Life Technologies). Total kidney RNA (18 g) from each experimental animal was loaded into individual wells and separated by 1.0% agarose formaldehyde gel electrophoresis. A photomicrograph of the ethidium bromide-stained gel was obtained to determine RNA loading equality. The RNA was transferred to a hybridization membrane (GeneScreen Plus; New England Nuclear Life Science Products, Boston, MA) and ultraviolet light crosslinked (UV Crosslinker; Hoeffer Scientific Instruments, San Francisco, CA). Complementary DNA probes were radiolabeled with 32 P dCTP (3000 Ci/mmol) by random priming with T 7 Quick Prime kit (Pharmacia Biotech, Piscataway, NJ). The blots were hybridized with the radiolabeled cDNA probes using the QuickHyb hybridization buffer (Stratagene, La Jolla, CA). Autoradiographs were obtained and the density of each band quantified using the NIH Image program. The 18-s ribosomal bands in the ethidium bromidestained gels were used to adjust for RNA loading equality as described previously (36) .
The cDNA probes used were murine uPAR1 (from Dr. Niels Behrendt, Finsen Laboratory, Copenhagen, Denmark) (37), rat fibronectin lambda-rlf-1 (from Dr. 
Protease Activity
Protein was isolated from kidney tissue that had been stored at Ϫ80°C. Pieces were individually ground into a fine powder under liquid nitrogen conditions, using a mortar and pestle that had been prechilled with dry ice. For gelatin zymography, the powder was homogenized in extraction buffer (0.05 M Tris, 0.01 M CaCl 2 , 2.0 M guanidine HCl, 0.2% Triton X-100, pH 7.5) and dialyzed using dialysis membrane Spectra/Por R 1 (Spectrum Medical Industries, Inc., Houston, TX) against 0.05 M Tris, 0.2% Triton X-100, pH 7.5, for 48 h at 4°C. For casein plasminogen zymography, the powder was mixed with homogenizing buffer (50 mmol/L Tris, pH 7.6, 1% SDS). Individual samples were then centrifuged for 5 min (14,000 ϫ g), and the protein concentration was measured in the supernatants using the Bradford protein assay kit (Bio-Rad, Hercules, CA). Samples were aliquoted and stored at Ϫ80°C for zymographic studies.
MMP-9 and MMP-2 activity were measured by gelatin zymography according to the method reported by Kenagy et al. (46, 47) . In brief, protein samples (10 g/well) were loaded without heating onto a 7% polyacrylamide gel containing 1 mg/ml porcine skin gelatin (Sigma) as substrate. Molecular markers and human MMP-2 and MMP-9 standards (Chemicon International Inc., Temecula, CA) were also loaded into the outer wells. After protein separation by electrophoresis, the gel was rinsed in 2.5% Triton X-100 at room temperature with gentle shaking for 30 min. After incubation for 17 to 20 h at 37°C in a solution containing 50 mM Tris and 10 mM CaCl 2 , pH 7.8, the gel was stained with 0.002% Coomassie blue and photographed. The size of each lytic band was measured using the NIH image analysis program.
Casein plasminogen zymography was performed to evaluate renal uPA and tPA activity using the methods of Roche et al. (48) with minor modifications as described previously (9) . The procedure used was similar to gelatin zymography, except that the zymography gel was made of 10% SDS-polyacrylamide containing 2 mg/ml ␣-casein and 10 g/ml plasminogen (Sigma). Molecular weight markers and human urokinase standards (Calbiochem Co., San Diego, CA) were loaded into the outer wells. PA-specific bands were verified by their disappearance when re-run in an identical gel that lacked plasminogen.
Total kidney plasmin activity was measured using a plasminspecific chromogenic substrate, Chromozym PL (Boehringer Mannheim, Indianapolis, IN) as described previously (9) .
TGF-␤ Bioactivity
TGF-␤ bioactivity was measured in kidney protein extracts using a TGF-␤-responsive mink lung epithelial cell (MLEC) line (a generous gift from Dr. Daniel B. Rifkin, New York University Medical Center, New York, NY) (49). This cell line was generated by fusing a truncated TGF-␤-inducible PAI-1 promoter to a firefly luciferase reporter gene and transfected into MLEC. This bioassay is specific for active TGF-␤ with a detection limit of approximately 5 to 10 pg/ml. Kidney protein samples (15 g) diluted in serum-free media (triplicate samples from three individual animals per group) were added directly to monolayers of confluent MLEC cultures. A standard curve of TGF-␤1 activity was generated using serial dilutions of recombinant human active TGF-␤1 (ED 50 ϭ 0.05 to 0.1 ng/ml; Amersham Pharmacia). After overnight incubation at 37°C in 5% CO 2 , cells were harvested and luciferase activity measured using the Enhanced Luciferase Assay Kit (Pharmingen, San Diego, CA).
HGF Western Blotting
Pro-HGF and the active form of the HGF protein (␣ chain) were detected by Western blot analysis as described by Grenier et al. (50) . Protein samples (40 g) were separated by 10% SDS-PAGE under reducing conditions. The proteins were transferred to a nitrocellulose membrane, and the immunoreactive protein was visualized using ECL enhanced chemiluminescence (Amersham Pharmacia Biotech Inc., Piscataway, NJ). The primary antibody was monoclonal anti-human HGF (clone 8), known to crossreact with rat HGF (30); the secondary antibody was HRP-conjugated goat anti-mouse IgG (Sigma). Protein loading equality was determined by amido black staining.
Statistical Analyses
All results were expressed as mean Ϯ 1 SD. Results were analyzed by the Mann Whitney U test. A P value Ͻ 0.05 was considered statistically significant.
Results
Renal Expression of uPAR and LDL-Receptor Related Protein
Renal uPAR mRNA was undetectable by Northern blotting in sham-operated kidneys and remained undetectable in all UUO kidneys from uPARϪ/Ϫ mice. UPAR mRNA was expressed in UUO kidneys from the uPARϩ/ϩ mice animals after 3 d of obstruction (Figure 1) . In situ hybridization studies on kidneys after 7 and 14 d of obstruction identified uPAR transcripts in uPARϩ/ϩ kidneys, especially in tubular and interstitial cells (Figure 2 ). Expression of LRP by interstitial cells, an endocytosis receptor that functions as an uPAR coreceptor, was increased to a greater extent in the uPARϩ/ϩ mice than the uPARϪ/Ϫ mice after ureteral obstruction (Figure 3) .
Severity of Tubulointerstitial Fibrosis
In response to UUO, total kidney collagen increased with time in the mice of both genotypes, reaching a 2.6-fold to 3.6-fold increase relative to the sham kidneys by day 14 UUO (uPARϩ/ϩ and Ϫ/Ϫ, respectively; Figure 4) . The increase in kidney collagen was significantly higher in the uPARϪ/Ϫ mice: 7.6 Ϯ 0.9 compared with 6.3 Ϯ 0.6 g/mg kidney at day 7 UUO and 13.5 Ϯ 1.5 versus 9.8 Ϯ 1.0 g/mg kidney at day 14 UUO (uPARϪ/Ϫ versus uPARϩ/ϩ; P Ͻ 0.05). Evaluation of the interstitial area stained blue with Masson trichrome also demonstrated that interstitial fibrosis was significantly more extensive in the uPARϪ/Ϫ kidneys (Figure 4) . Tubular injury was more severe in the uPARϪ/Ϫ mice. The number of Ksp-cadherin-positive collecting ducts was significantly reduced in the uPARϪ/Ϫ group within 3 d after UUO (Figure 5 ), and they were undetectable in both genotypes by 14 d. Using PHA-E lectin staining to evaluate late proximal tubular damage, even after 14 d of obstruction the uPARϩ/ϩ mice had less extensive tubular destruction ( Figure 5 ). 
Renal Expression of PA and PA Inhibitor Genes
Renal expression of plasminogen activator genes was increased to a similar extent in the mice of both genotypes in response to UUO (twofold and threefold increase in uPA and tPA, respectively, at day 7 UUO; Figures 6 and 7) . Renal mRNA levels of the two renal serine protease inhibitors, PAI-1 and protease nexin-1, were also strongly induced in response to UUO and to a similar level in uPARϩ/ϩ and Ϫ/Ϫ mice (Figures 6 and 7) . In contrast, renal mRNA levels for the plasmin inhibitor ␣2-antiplasmin were significantly downregulated in mice of both genotypes in response to UUO (Figures 6 and 7) . Renal plasminogen mRNA was undetectable in all kidneys.
Renal Protease Activity
As illustrated in casein plasminogen gel zymogram ( Figure  8) , uPA is the predominant plasminogen activator detected in the kidney after UUO. The activity of both uPA and tPA increased with time after UUO, but both were significantly lower in the uPARϪ/Ϫ mice compared with uPARϩ/ϩ mice. By immunostaining, uPA protein was detected in renal tubules in a similar pattern in both genotypes, including enhanced expression in dilated atrophic tubules found within fibrotic loci (Figure 8 ). Renal plasmin activity did not differ between uPARϩ/ϩ and Ϫ/Ϫ mice: sham: 2.7 Ϯ 0.8 versus 2.4 Ϯ 0.5; day 3 UUO: 3.2 Ϯ 2.4 versus 5.3 Ϯ 1.0; day 14: 2.0 Ϯ 1.5 versus 3.1 Ϯ 2.1 ϫ 10 Ϫ4 units/ml, respectively. Gelatin gel zymography demonstrated that MMP-9 was the most abundant gelatinase in the kidney. After UUO surgery, MMP-9 activity decreased compared with the sham kidneys; MMP-9 activity was significantly lower in the uPARϪ/Ϫ mice compared with uPARϩ/ϩ mice on days 3 and 14 ( Figure 9 ). In contrast, renal MMP-2 activity increased in response to UUO without a consistent difference between the two genotypes: MMP-2 levels slightly lower (nonsignificant) on days 3 and 7 but higher (significant) by day 14 in the uPARϪ/Ϫ mice ( Figure 9 ).
TGF-␤1
Renal TGF-␤1 mRNA was strongly induced in UUO kidneys from mice of both genotypes after 3, 7, 14 d of obstruction: eightfold, fivefold, and fourfold in the uPARϩ/ϩ mice and sixfold, sevenfold, and fivefold in the uPARϪ/Ϫ mice at 3, 7, and 14 d, respectively (nonsignificant differences between the genotypes; Figure 10 ). Immunohistochemical staining of the obstructed kidneys identified TGF-␤1 protein primarily in renal tubules and occasional interstitial cells (Figure 10 ). In contrast to the mRNA levels, TGF-␤1 bioactivity was actually significantly lower in the uPARϪ/Ϫ kidneys compared with the uPARϩ/ϩ kidneys after 7 d of obstruction (Figure 10 ).
Hepatocyte Growth Factor
In vitro studies have reported that urokinase activates the anti-fibrotic growth factor HGF (51). Seven days after UUO surgery, all four HGF transcripts (6.0, 3.1, 2.3, and 1.5 kb) were significantly increased; levels of the major 2.3-kb transcript were significantly lower in the uPARϪ/Ϫ mice ( Figure  11 ). By immunohistochemistry, the HGF protein was detected within the interstitium. Western blot analysis (day 7) showed significantly lower levels of active HGF (␣ chain) in the uPARϪ/Ϫ mice despite similar amounts of pro-HGF protein in both genotypes (Figure 11) . By day 14, HGF protein could not be detected by Western blotting.
Extracellular Matrix Genes
Renal procollagen ␣1(I) and fibronectin mRNA level was significantly elevated in mice of both genotypes after UUO compared with sham-operated groups ( Figure 12 ). As shown, no differences were noted between the uPARϪ/Ϫ and uPARϩ/ϩ mice on day 14 after UUO. Although not shown, matrix gene expression was also similar on days 3 and 7.
Discussion
The uPAR is a multifunctional cellular receptor that is involved in such diverse biologic processes as angiogenesis, inflammation, wound repair, and tumor metastasis (12, 21) . The results of the present study identify an important modulating role for uPAR during the renal fibrogenic response that develops in response to chronic injury caused by ureteral obstruction. Although there are now several reports of increased uPAR expression in damaged kidneys, the functional significance of these changes remains unclear. In the present study, renal uPAR was significantly increased after ureteral obstruction in wild-type mice, while the absence of uPAR in the uPAR null mice was associated with a more aggressive fibrogenic re- sponse. The ability of uPAR to attenuate renal fibrosis appears to be related, at least in part, to enhanced activity of proteases that degrade extracellular matrix proteins, including uPA, tPA, and possibly MMP-9.
The kidney is the major site of production of the uPAR ligand, uPA. Other known ligands are kininogen and vitronectin (12, 52) . In response to UUO, renal pro-urokinase mRNA levels were significantly increased in mice of both genotypes but uPA activity was significantly higher in the uPARϩ/ϩ animals, consistent with the known ability of uPAR to stabilize uPA activity at cellular surfaces. uPAR binds both the single chain pro-urokinase and the two-chain active enzyme. Even after receptor binding, pro-urokinase can be activated while the active enzyme is stabilized. The specific mechanism(s) of pro-urokinase activation within the kidney is unknown; several enzymes can achieve this function in vitro, including plasmin, kallikrein, cathepsins, matrix metalloproteinase-3, and Pump-1 metalloproteinase (53). In the present study, the renal expression of uPAR in the wild-type mice after UUO was associated with significantly higher levels of uPA activity than was observed in the kidneys lacking uPAR.
Urokinase initiates several extracellular events that could accelerate the rate of degradation of matrix proteins. It has limited ability to directly degrade some matrix proteins such as fibronectin (54) . It also activates certain latent matrix metalloproteinases, including membrane type (MT)-MMP-1 and MT-MMP-2 (55). However, it is the ability of uPA to catalyze the conversion of plasminogen to plasmin and the subsequent plasmin-dependent activation of metalloproteinases, especially interstitial collagenase (MMP-1) and stromelysin-1 (MMP-3), that has been considered to be the primary pathway whereby uPA promotes the degradation of extracellular matrix (56) . Significantly less MMP-9 activity, the predominant renal gelatinase, was detected in the uPARϪ/Ϫ kidneys 3 and 14 d after UUO, which may be one factor contributing to the greater extent of renal fibrosis. Whether alterations in MMP-1 or MMP-3 activity are involved remains speculative, as we have not been able to detect MMP-1 or MMP-3 activity using kidney protein extracts and casein and gelatin zymography.
Recent fibrosis studies in plasminogen-deficient mice have yielded conflicting data and suggest that the plasmin-dependent effects could be tissue-specific. Accelerated fibrosis has been reported in the model of bleomycin-induced pulmonary fibrosis in mice genetically deficient in plasminogen (57), while renal fibrosis induced by UUO was not accentuated in the absence of plasminogen (58) . By contrast, in acute glomer- Figure 6 . Renal expression of PA and PA inhibitor genes. Representative Northern blot from day 7 studies illustrates specific bands for plasminogen activators uPA (A) and tPA (B), and the inhibitors PAI-1 (C), protease nexin-1 (D), ␣2-antiplasmin (E). The changes in response to UUO were similar between the uPARϩ/ϩ and Ϫ/Ϫ genotypes except for ␣2-antiplasmin levels that were downregulated to a lesser extent in the uPARϪ/Ϫ mice (P Ͻ 0.05). The bands of 18S rRNA in the ethidium bromide stained gel showed the equality of RNA loading. ular injury associated with fibrin deposition, plasminogen deficiency exacerbates the disease severity (59) . In the present study, plasminogen mRNA was not detected in any of the kidneys, and measured renal plasmin activity was unaltered by genotype. We cannot discount the possibility that technical limitations of the plasmin assay accounted for the failure to detect genotype-dependent differences in renal plasmin activity. Alternatively, other regulators of plasmin activity may overshadow plasminogen activator activity in this model. Paradoxically, plasmin may also activate latent TGF-␤, at least in vitro (7) ; whether this is a significant in vivo response is unclear. In the present study, TGF-␤ bioactivity was actually higher in the wild-type mice, yet the net effect of upregulated uPAR expression was enhanced PA activity and less interstitial collagen deposition.
Urokinase has been reported to induce the expression and activation of HGF, a growth factor with important anti-fibrotic activities (51) . HGF has been reported to attenuate renal fibrosis in several experimental models (34,60 -63) . In this study, the renal response to UUO was characterized by an increase in the expression of all four HGF mRNA transcripts. The predominant 2.3-kb transcript was significantly higher in the uPARϩ/ϩ than the uPARϪ/Ϫ mice. HGF protein deposited in the interstitium of the obstructed kidneys and may have con- tributed to the dampened fibrogenic response observed in the uPAR wild-type mice given that levels of the active HGF alpha chain were higher in the obstructed wild-type kidneys.
The other known uPAR ligands, high-molecular weight kininogen (64) and vitronectin, are also increased in the kidney in response to ureteral obstruction. While not investigated in Figure 8 . Zymogram of renal plasminogen activator activity. Lytic bands representing renal tPA (65 kD) and uPA (40 kD) activity, as measured by casein plasminogen zymography in uPARϩ/ϩ and Ϫ/Ϫ mice (A). Semiquantitative evaluation of the uPA and tPA (B) was performed using the NIH Image program, and the results are expressed as the mean Ϯ 1 SD (n ϭ 3 per group). * P Ͻ 0.05, uPARϪ/Ϫ versus uPARϩ/ϩ mice. Photomicrograph of uPA immunoperoxidase staining, illustrating numerous positive tubules in an uPARϪ/Ϫ kidney 7 days after UUO. Magnification: ϫ400. this study, it is possible that uPAR-kininogen interactions also mediate renoprotective effects, as kallikrein gene therapy has been reported to attenuate glomerulosclerosis in the remnant kidney model, a therapy that was associated with increased urinary kinin excretion (65) . High-molecular weight kininogen may indirectly promote the activation of uPAR-bound prourokinase, as it serves as a prekallikrein receptor, thereby juxtaposing latent uPA and one of its activators at cellular surfaces (66) .
In addition to its ability to amplify uPA activity, uPAR may modulate cellular behavior (12, 67, 68) . Although uPAR itself is attached to the plasma membrane via a GPI anchor that lacks an intracellular domain, uPAR can dimerize with other cellular receptors to initiate numerous cell surface and intracellular events. Most relevant to the present study, uPAR interacts with the scavenger receptor LDL receptor-related protein (LRP) (69) . This interaction appears to be the primary pathway for clearance of extracellular PAI-1 after it binds to uPAR-uPA (5) . In the present study, renal interstitial cells were shown to express LRP protein by immunostaining and the area stained was reduced in the uPARϪ/Ϫ mice. The uPAR is also expressed by several interstitial cells in the wild-type mice, indicating that the uPAR-LRP scavenger receptor complex is co-expressed by renal interstitial cells and is theoretically available for PAI-1 clearance. Increased PAI-1 accumulation could explain why tPA activity, as well as uPA activity, was significantly reduced in the uPARϪ/Ϫ mice.
It is also noteworthy that LRP is an endocytosis receptor for multiple ligands, including fibronectin (70) , and has recently been identified as the receptor for connective tissue growth factor (71) , both important components of the fibrogenic response. uPAR is also known to dimerize with members of the integrin superfamilies (␤1, ␤3, and ␤5), interactions that may trigger intracellular signaling responses and promote cell adhesion and migration. Given that uPA and its receptor are also strongly expressed by tubular cells during UUO, it is possible that uPA-uPAR-dependent cellular signaling responses may promote tubular survival within a fibrosing environment. Although the present study does not prove that the observed increase in plasminogen activator activity is the major reason for the less aggressive fibrogenic response observed in the uPAR wild-type mice, it is noteworthy that the levels of increased expression of the genes encoding the interstitial matrix proteins fibronectin and procollagen I were similar in the wild-type and knockout mice, suggesting that altered rates of matrix synthesis do not explain the differences. In contrast with the findings in this study, deficiency of uPAR failed to alter the degree of pulmonary interstitial fibrosis in mice treated with bleomycin (57) . However, in that model tPA may be a more important plasminogen activator as fibrin (the primary tPA substrate) accumulation is significant and may play an important pathogenetic role, although data on the latter point are conflicting (10, (72) (73) (74) (75) . It may also turn out that plasmin activity is more important in the lung than it is in the kidney on the basis of the initial studies using plasminogendeficient mice. Nonetheless, these findings suggest that uPAbased therapies may represent a novel therapeutic approach for progressive renal disease. In fact, uPA therapy administered to animals with bleomycin-induced lung disease using adenoviral gene vectors or recombinant protein, has been reported to reduce fibrosis (76, 77) . Although the results of uPA therapy in chronic tubulointerstitial disease have not yet been reported, recombinant tPA treatment has been reported to reduce the extent of glomerular matrix accumulation in rats with Thy-1 nephritis (78) .
In summary, the results of the present study suggest that within the kidney uPAR helps to regulate the intensity of the fibrogenic response to chronic damage, at least in part by increasing the activity of plasminogen-activating proteases. Whether polymorphisms in the uPAR gene (79) correlate with the risk of renal disease progression and whether therapeutic interventions designed to enhance uPAR expression and activity can be protective are questions deserving of future investigation.
